
CAS 1096708-71-2
:Fórmula:C17H12Cl2F3N7O2S
InChI:InChI=1S/C17H12Cl2F3N7O2S/c1-6(28-15(31)12-11(19)13(23)27-5-26-12)16-25-4-9(32-16)14(30)29-10-2-7(17(20,21)22)8(18)3-24-10/h2-6H,1H3,(H,28,31)(H2,23,26,27)(H,24,29,30)/t6-/m1/s1
Clave InChI:VWMJHAFYPMOMGF-ZCFIWIBFSA-N
SMILES:C[C@H](C1=NC=C(S1)C(=O)NC2=NC=C(C(=C2)C(F)(F)F)Cl)NC(=O)C3=C(C(=NC=N3)N)Cl
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Se han encontrado 8 productos.
4-Pyrimidinecarboxamide, 6-amino-5-chloro-n-[(1r)-1-[5-[[[5-chloro-4-(trifluoromethyl)-2-pyridinyl]amino]carbonyl]-2-thiazolyl]ethyl]-
CAS:Fórmula:C17H12Cl2F3N7O2SPureza:99%Forma y color:SolidPeso molecular:506.2891Ref: IN-DA008TIA
50mgA consultar100mgA consultar250mgA consultar1mg81,00€2mg116,00€5mg184,00€10mg222,00€25mg570,00€Tovorafenib
CAS:(R)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamideFórmula:C17H12Cl2F3N7O2SPureza:99%Peso molecular:506.29TAK-580
CAS:TAK-580 (MLN2480) is an oral, selective pan-Raf kinase inhibitor in Clinicalal trials.Fórmula:C17H12Cl2F3N7O2SPureza:99.60% - 99.77%Forma y color:White SolidPeso molecular:506.29MLN2480
CAS:Producto controladoApplications MLN2480 is a RAF inhibitor that is used for the treatment of melanoma.
Fórmula:C17H12Cl2F3N7O2SForma y color:NeatPeso molecular:506.29BIIB-024
CAS:BIIB-024 is a monoclonal antibody that targets mutant melanoma cells. It binds to the tumor and prevents it from growing, as well as preventing the cancer cells from spreading. BIIB-024 has shown effectiveness in clinical studies by reducing tumor size and skin reactions in patients with melanoma. The effective dose of BIIB-024 is 10 milligrams per kilogram of body weight. BIIB-024 also inhibits protein synthesis in tumor cells, which may be due to its ability to bind to cytosolic proteins.
Fórmula:C17H12Cl2F3N7O2SPureza:Min. 95%Peso molecular:506.29 g/mol







